23 May 2013
Keywords: merck, co, team, galapagos, in195m-euro, deal, belgian
Article | 22 April 2009
Belgian drug developer Galapagos has entered into a multi-year global strategic alliance with USA-based Merck & Co to develop new therapies
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 April 2009
21 April 2009
22 May 2013
© 2013 thepharmaletter.com